1.13.13 Cellular Immortalization Definition
Cellular immortalization refers to the process by which cancer cells bypass normal lifespan limits, enabling uncontrolled growth and division.
Cellular Immortalization Definition is the precise characterization of the overall process by which a cell lineage transitions from a finite, mortal proliferative capacity to an unlimited, indefinite capacity for continued division, encompassing the full sequence of events required to overcome both replicative senescence and telomere crisis. Cellular immortalization is defined as the composite biological process, rather than any single molecular event, through which a cell population becomes capable of unlimited serial passage without entering senescence or succumbing to crisis-associated genomic catastrophe, culminating in the establishment of an immortalized cell lineage.
Formally, a cell lineage is considered immortalized once experimental serial passage, or equivalent sustained in vivo proliferation, demonstrates indefinite continued division well beyond the number of population doublings expected under the Hayflick limit for the corresponding normal cell type, accompanied by evidence of an active telomere maintenance mechanism sufficient to explain this extended proliferative capacity.
Sequential Steps in the Immortalization Process
Bypass of Replicative Senescence
The first requirement for immortalization is inactivation of the p53 and RB tumor suppressor pathways sufficient to prevent the cell cycle arrest that would otherwise be triggered upon initial telomere dysfunction, allowing continued division beyond the point at which a normal cell would enter replicative senescence.
Survival Through Telomere Crisis
Continued division following senescence bypass, in the absence of telomere maintenance, leads to progressively more severe telomere dysfunction and eventual entry into crisis, a state of extensive genomic instability and widespread cell death from which only rare cells emerge as surviving, immortalized clones.
Acquisition of a Telomere Maintenance Mechanism
Successful emergence from crisis as an immortalized lineage requires acquisition of either telomerase reactivation or the alternative lengthening of telomeres pathway, providing the sustained telomere maintenance capacity necessary to prevent further progressive telomere-driven instability.
Experimental Contexts
Spontaneous Immortalization
In laboratory settings, spontaneous immortalization of cultured cell populations occasionally occurs through the same sequential process described above, arising from the low-frequency accumulation of the necessary senescence-bypassing and telomere-maintaining alterations within a serially passaged population.
Deliberate Experimental Immortalization
Researchers have also developed deliberate methods of cellular immortalization, most commonly through introduction of viral oncoproteins that inactivate p53 and RB function, often combined with ectopic expression of telomerase, to generate stable, indefinitely proliferating cell lines for experimental use without requiring the natural, low-frequency process of spontaneous immortalization.
Distinction from Related Concepts
Immortalization Versus Malignant Transformation
Cellular immortalization is a necessary but not by itself sufficient condition for full malignant transformation; an immortalized cell line may lack other cancer-associated properties, such as anchorage-independent growth or the capacity to form tumors upon transplantation into a host organism, distinguishing immortalization as a specific, addressable component of the broader transformation process rather than a synonym for malignancy itself.
Relevance to Cancer Biology
Cellular immortalization represents the complete process by which the telomere-based constraint on proliferative capacity is definitively overcome, and it is considered one of the essential enabling capabilities that a cell lineage must acquire, alongside sustained proliferative signaling and evasion of cell death, in order to support the sustained, large-scale expansion characteristic of a clinically significant tumor.